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Reactive oxygen metabolites produced during phagocytosis are important for the 
microbicidal  activity  of granulocytes  and  probably  of monocytes  as  well  (1,  2). 
Although  the  role  of reactive  oxygen  metabolites  in  the  microbicidal  activity  of 
macrophages  is  not  established,  recent  studies  (3-6)  suggest  that  they  may  be 
important because activated macrophages that exhibit enhanced antimicrobial activ- 
ity produce increased  amounts of these  metabolites  in  response to  various stimuli. 
Because  reactive  oxygen metabolites  are  potentially  lethal,  organisms  that  survive 
within phagocytes must either fail to stimulate production of such substances or must 
be resistant to or fail to encounter them. One such intracellular organism is Toxoplasma 
gondii.  This organism survives and replicates in vitro within human monocyte-derived 
macrophages and within normal mouse macrophages (7-10).  However, other mono- 
nuclear phagocytes can kill or inhibit multiplication of Toxoplasma. For example, we 
recently  have  observed  that  Toxoplasma  is  rapidly  destroyed  by  freshly  isolated 
human blood monocytes (11).  In addition,  macrophages can be activated to kill  or 
inhibit  intracellular replication of Toxoplasma (7-9), and normal macrophages can 
kill  the  organism  if  it  is  coated  with  antibody  (12,  13). Because  the  ability  of 
Toxoplasma to survive within  mononuclear phagocytes depends  upon  the stage of 
differentiation  or state  of activation of mononuclear phagocytes and  also  depends 
upon whether the organism is opsonized, we studied the oxidative metabolic burst by 
different mononuclear phagocytes during phagocytosis of Toxoplasma. These studies 
were performed to determine  the relationship  between  survival of this  intracellular 
pathogen  and  production  of toxic  oxygen  metabolites  by  these  cells.  The  results 
revealed  that  the  ability  of this  organism  to  survive  within  certain  mononuclear 
phagocytes is  dependent  in  part  upon  its  being phagocytosed without  stimulating 
production of reactive oxygen metabolites by these cells. 
Materials and Methods 
Special Reagents.  Reagents were obtained from Sigma Chemical  Co., St. Louis, Mo., unless 
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otherwise indicated.  Nitroblue tetrazolium  (NBT) 1 was dissolved in Krebs-Ringer phosphate 
buffer (pH  7.4)  with 5.5 mM glucose (KRPG),  and superoxide dismutase  (SOD)  (=2,900  U/ 
mg) was dissolved in phosphate-buffered saline (pH 7.2)  (PBS); each was sterilized by filtration 
before use.  When  indicated,  SOD was  inactivated  by autoclaving at  120°C  for 20  min;  this 
resulted in the loss of =  90% of activity. 
Cell Preparations.  Blood was obtained  from healthy adult  donors and  from a  child with X- 
linked chronic granulomatous  disease (CGD), his heterozygote mother, and  his normal sister; 
each donor lacked antibodies to Toxoplasma in the Sabin-Feldman  dye test  (DT). Leukocytes 
were obtained by separation of blood on Ficoll (Pharmacia Fine Chemicals, Div. of Pharmacia 
Inc.,  Piscataway,  N. J.)  -Hypaque  (Winthrop  Laboratories,  New  York)  (FH)  gradients  (14). 
The erythrocyte-polymorphonuclear leukocyte (PMN)  pellet was resuspended  in Tris-buffered 
0.83% NH4CI for 10 min to lyse erythrocytes, and PMN were collected by centrifugation. PMN 
and mononuclear cells were washed in KRPG and resuspended in KRPG; these are referred to 
as  human  PMN  and  human  mononuclear  cell  preparations  (MCP).  For  preparation  of 
monolayers of monocytes, mononuclear cells were washed twice in Hanks' balanced salt solution 
(HBSS)  (Grand Island Biological Co., Grand  Island,  N. Y.) and  resuspended  in Medium  199 
(Grand Island Biological Co.) that contained  100  U/ml penicillin G, 100 p,g/ml streptomycin, 
2 mM L-glutamine (M199),  and 40% autologous serum  (M199 +  AS) before plating.  In some 
experiments, mononuclear cells were depleted of monocytes by using a  magnet to remove cells 
that  phagocytosed carbonyl iron and then by using glass adherence. 
Macrophages were derived by in vitro culture of human  monocytes for 5-6 d, as previously 
described (7). Transformation of monocytes into macrophages was confirmed by characteristic 
morphology  (15)  and  by  absence  of  histochemically  detectable  peroxidase  (16).  Human 
macrophages  were  obtained  in  suspension  by  washing  Petri  dishes  in  HBSS,  incubating 
monolayers in Ca ++- and Mg++-free HBSS at 4°C for 30 min to facilitate cell detachment, and 
gently resuspending the cells with a  rubber policeman. The macrophages  in suspension  were 
then washed twice in KRPG and resuspended  in KRPG. 
Unelicited peritoneal  cells were obtained  from  6-  to 8-wk-old  Swiss Webster  female mice 
(Simonsen  Laboratories,  Gilroy,  Calif.),  as  previously  described  (17).  Peritoneal  cells  were 
resuspended  in M199  that  contained  20% heat-inactivated  fetal' calf serum  (M199  +  FCS) or 
were washed once in KRPG and resuspended  in KRPG, as described for human  MCP; when 
used in suspension,  these are referred to as mouse MCP.  In some experiments, peritoneal cells 
were  depleted  of phagocytic  and  adherent  cells,  as  described  for human  mononuclear  cells. 
Peritoneal cell preparations rich in PMN were obtained from mice injected intraperitoneally  16 
to  18  h  previously  with  1  ml  of sterile  thioglycollate  broth.  Mouse  MCP  that  contained 
macrophages  that  were activated  (i.e.,  that  inhibited  intracellular replication of Toxoplasma 
[9,  18]) were  obtained  from  mice chronically  infected  with  T.  gondii  or  from  mice  injected 
intraperitoneally  7  d  earlier  with  1,400  p.g  of formalin-killed  Corynebacterium parvum  (lot  no. 
CA582A;  Burroughs  Wellcome  Co.,  Research  Triangle  Park,  N.  C.).  Control  MCP  were 
obtained from age-matched  mice. To decrease the number of contaminating PMN, cells from 
C. parvum-injected mice and cells from  the controls  for these experiments were centrifuged on 
FH gradients before washing in KRPG. 
Human and  mouse MCP were used within  1 h  after they were isolated. The percentage of 
PMN in cell preparations was determined by differential counts of Giemsa-stained smears; the 
percentage  of  monocytes  or  macrophages  was  determined  by  phagocytosis  of  neutral  red 
particles  (14,  19).  Human  MCP  contained  21.0  +  1.1%  monocytes  and  1.2  +  0.3%  PMN; 
human  macrophage  preparations  contained  100%  macrophages;  MCP  from  normal  mice 
contained  75.1  +  2.5%  macrophages  and  2.8 __. 0.9%  PMN;  MCP from mice injected with C. 
parvum  contained  47.8  +  7.9%  macrophages  and  3.0  +  0.9%  PMN;  and  MCP  from  mice 
chronically infected with  T. gondii contained 45.0 +  3.8% macrophages  and  1.3 +  0.5% PMN. 
Abbreviations used m this paper: CGD, chronic granulomatous disease; DT, Sabin-Feldmao dye test;  FH, 
Ficoll-Hypaque; HBSS, Hanks'  balanced salt  solution; HMP, hexose  monophosphate;  H202,  hydrogen 
peroxide;  KRPG, Krebs-Ringer phosphate buffer  (pH 7.4) with 5.5 mM glucose; M199, Medium  199 that 
contained  100 U/ml penicillin G, 100 mg/ml streptomycin, 2 mM L-glutamine;  M 199 +  AS, M 199 with 
40% autologous  serum; M199 +  FCS, M199 that contained 20% heat-inactivated fetal calf serum; MCP, 
mononuclear cell  preparation(s);  NBT, nitroblue  tetrazolium; Oz-, superoxide anion;  PBS,  phosphate- 
buffered  saline (pit 7.2); PMN, polymorphonuclear leukocyte(s);  SOD, superoxide dismutase. 330  SURVIVAL  OF  INTRACELLULAR  PATHOGENS  WITHIN  MACROPHAGES 
Organisms and Latex.  Yeast-phase Candida albicans were killed by boiling for 30 min and were 
washed  in  PBS  and  stored  at  4°C  in  PBS.  Latex  particles  (0.3-  or  2-/~m  in  diameter;  Dow 
Chemical Co., Midland, Mich.) were washed six times in PBS, sonicated to produce a  uniform 
suspension, and diluted to 2% in KRPG  before use. The  RH  strain of T  gondii was obtained 
and processed as previously described  (9), except that polycarbonate membrane filters (3-p,m 
pore  diameter;  Nuclepore  Corp.,  Pleasanton,  Calif.)  were  used  to  purify  Toxoplasma.  Such 
preparations contained <  1 leukocyte/104 Toxoplasma. 
Quantitative Reduction of NBT.  Quantitative reduction of NBT was determined by a  modifi- 
cation of the method of Baehner and Nathan (20). Candida were opsonized at 37°C for 30 min 
in  2  ml of KRPG  and  2  ml of human  type AB serum, washed,  and resuspended  in  KRPG. 
Toxoplasma  were washed once and resuspended  in  KRPG.  Both Candida  and Toxoplasma 
were  then counted  in a  hemacytometer and adjusted  to  the  desired  concentration.  In  some 
experiments, Toxoplasma were incubated at 37°C  for 30 min in 80% immune serum and 20% 
KRPG, centrifuged, washed twice in KRPG, and resuspended in KRPG; such organisms were 
antibody coated  (12).  Immune sera were from two human subjects  (DT  titers of 1:32 and  l: 
256) or from mice chronically infected with Toxoplasma  (DT titer of 1:4096; this was diluted 
1:10 in normal serum before use). To insure that organisms would remain viable, immune sera 
were heat inactivated (12) at 53°C for 90 min before use (21). DT-negative human and mouse 
sera were  used  as controls.  Results of experiments in  which Toxoplasma  were  incubated  in 
heat-inactivated or noninactivated DT-negative serum were identical with those in which they 
were not incubated in serum. 
Components of the reaction mixtures, as indicated in the appropriate table, were added  to 
siliconized glass tubes, and tubes were placed on a  rotater in a  37°C incubator and rotated at 
100 cycle/min for 30 min. This time period was found in preliminary experiments to result in 
maximum increments in NBT reduction between resting and phagocytosing cell preparations. 
Thereafter, reaction mixtures were processed and assayed as described by Baehner and Nathan 
(20),  except  that  the  reduced  dye  was  extracted  in  3  ml  of pyridine.  The  amount  of NBT 
reduced was calculated with the extinction coefficient E  =  2.8 mM -I cm  -I (22). 
lntracellular Location of Reduced  NBT.  Monolayers of each cell type were prepared in Lab-Tek 
tissue  culture  chamber/slides  (Lab-Tek  Div.,  Miles  Laboratories  Inc.,  Naperville,  Ill.)  (23). 
After medium was aspirated from the monolayers, 0.5 ml that contained  1 X  10  6 Candida or 
2 ×  106 Toxoplasma and 0.1  ml of NBT (1  mg/ml in M199) was added. Identical results were 
observed with monolayers of each cell type whether organisms were suspended in M199 +  AS, 
in M199 with 20% human type AB serum, or in M199 +  FCS  (all sera were negative in the 
DT). Slides were incubated at 37°C for varying periods of time, rinsed in warmed saline, fixed 
in  methanol, and counterstained with 0.2%  safranin. The  percentage of cells that  contained 
formazan-stained  organisms  within  phagocytic  vacuoles  was  determined  microscopically  by 
counting 100-200 cells that contained organisms (24). Only cells that contained organisms that 
were stained deeply blue were scored as formazan positive. Cells that contained only diffuse, 
fine deposits  of formazan  were  present  in  similar  numbers  in  challenged  and  unchallenged 
monolayers; they were therefore scored as negative. 
Intracellular survival  and  replication  of Toxoplasma  within  monocytes  and  macrophages 
was evaluated as previously described  (9). 
Chemiluminescence.  Chemiluminescence was determined as described by Rosen and Kleban- 
off  (25).  Components  of  the  reaction  mixtures  (experiments  performed  in  duplicate)  are 
indicated in the appropriate figure. The reaction was initiated by addition of organisms. Vials 
were placed in the scintillation counter, counted  for 24 s, and then placed  in a  37°C shaking 
water bath at 20 cycle/rain. At intervals, vials were blotted dry and returned to the scintillation 
counter,  counted  for  24  s,  and  then  placed  back  in  the water  bath.  Background  activity of 
empty vials was subtracted from test values; results are expressed as counts per minute above 
background. 
14C02 Production  from [1-14C]glucose.  Oxidation of [1-14C]glucose was determined by a  mod- 
ification of the method of Keusch et al. (26). Components of the reaction mixtures, as indicated 
in the appropriate table, were added to center-well flasks, and flasks were placed on a  rotator 
in a  37°C incubator and rotated at  100 cycle/min for 60 min. 14CO2 was trapped in a  cup that 
contained hyamine hydroxide, transferred to a  glass scintillation vial that contained  10 ml of C.  B.  WILSON, V.  TSAI, AND J.  S.  REMINGTON  331 
Aquasol (New England Nuclear Co.), and counted in a liquid scintillation counter. 
Evaluation of Phagocytosis.  At the end of the reaction period in each of the quantitative assays, 
a replicate reaction mixture of each type or a portion of each reaction mixture was diluted with 
an equal volume of ice-cold  10 mM disodium ethylenediaminetetraacetate  to stop phagocytosis 
and deposited on glass slides  with a cytocentrifuge. In a  few experiments, replicate reaction 
mixtures were not available because of an inadequate number of cells. Cytocentrifuge prepa- 
rations were  fixed  in methanol, stained with  Giemsa stain, examined microscopically, and 
scored  for phagocytosis by determining the percentage of cells that contained organisms and 
the total number of organisms ingested per  100 cells.  Results are expressed  as  a  phagocytic 
index, which is the mean number of organisms ingested per cell. 
The ratios of organisms to phagocytes used in each of the quantitative assays were found in 
preliminary  experiments to produce maximum increments in oxidative metabolic activity above 
base-line values and maximum phagocytic indices at the end of the reaction period. In some 
assays, a  higher Candida:cell ratio resulted in a  greater initial rate of metabolic activity but 
<10% difference at the end of the reaction period. We found, as have others (27), that accurate 
determination of  phagocytosis  of  latex  particles  by  cell  suspensions was  not  possible  by 
microscopic  techniques.  However,  the  ratios  employed  produced  maximum increments in 
metabolic activity, and > 90% of monocytes or macrophages ingested one or more latex particles 
by the end of the reaction period. 
Phagosome-Lysosome Fusion.  Fusion of lysosomes with phagosomes that contained Toxoplasma 
was assessed by the acridine-orange method of D'Arcy Hart and Young (28). Monolayers of 
human monocytes and mouse macrophages were cultured on glass cover slips in wells of Linbro 
trays (FB-16-24-TC; Linbro Chemical Co., Hamden, Conn.) and challenged with Toxoplasma 
as described above, except  that, before preparation of monolayers, MCP were  incubated in 
HBSS that contained 20 gg/ml of acridine orange for  15 rain, washed in HBSS, resuspended 
in  medium,  and  added  to  wells.  At  various  intervals after  the  addition  of Toxoplasma, 
monolayers were examined in a fresh state with a Zeiss incident light fluorescence microscope 
(Carl Zeiss, Inc., New York) equipped with an acridine-orange filter set. Phagosome-lysosome 
fusion was  considered to  have occurred when Toxoplasma, which were  initially unstained, 
became diffusely orange. 
Data Presentation and Statistical Analysis.  For values presented in the text, quantitative NBT 
reduction and ~4CO2 production stimulated by phagocytosis were determined by subtracting 
counts per minute for  resting cells  (and, when appropriate,  by also subtracting counts per 
minute for Toxoplasma preparations alone) from counts per minute for phagocytosing cells. 
Corrected and uncorrected values and values for preparations of resting cells and Toxoplasma 
are  given in the  tables.  Mean  ±  standard error was  employed unless otherwise  indicated. 
Statistical  differences  between  means  were  determined  using the  Student's  t  test.  Linear 
regression  lines were fitted to data points by the least squares method, and the significance of 
the correlation coefficient  (r) was determined by Student's t test. 
Results 
Quantitative  Reduction  of NBT.  NBT reduction increased significantly (P <  0.001) 
during phagocytosis  of Candida by  each  type  of cell  preparation  (Table  I).  The 
increase in NBT reduction by human MCP and human macrophages was significantly 
greater (P <  0.001) than that by normal mouse MCP. Phagocytosis of latex particles 
also effectively stimulated NBT reduction by each  type of cell preparation studied. 
The increase in NBT reduction by human MCP during phagocytosis of Toxoplasma 
was significantly greater than NBT reduction by resting cells  (P <  0.001)  although 
less than that observed during phagocytosis of Candida or latex particles. In contrast, 
the increase in NBT reduction by human macrophages and by normal mouse MCP 
during phagocytosis of Toxoplasma was not significantly greater than NBT reduction 
by resting cells. Relative amounts of NBT reduction were similar when the reaction 
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TABLE  I 
Quantitative Reduction of NBT* 
Phagocytic stimulus 
Cell preparation  None  Candida  Latex particles  Toxoplasma  A Toxoplasma/A Can- 
didall 
NBT red.:~  ~  NBT red.§  A NBT red.  A NBT red. 
Human mononuclear (I 1)¶  2.9 ±  1.0llll  43.6 ±  4.5  39.5 ±  83  11.2  ±  1.4  0.25 +  0.04 
Human macrophage  (4)  2.1  +  1.7  400 ±  8.3  72.1  +  13.6  1.9 ±  0.7¶I  0.04 ±  0.01¶¶ 
Mouse mononuclear 
Normal** (lfi)  1.9 ±  0.2  I7 9 ±  1.7"**  9.5 ±  2.9  1.9 ±  0.5~::H:  O.OB ±  0~02~$~c 
C~ parvum*:~ (4)  4.3 ::lz  0.7  20.7 ±  52  ND§§§  6.7 ±  2. ll[lllJ  0.31  +  0.04111111 
Chronic Yoxoplasma§§ (5)  3.8 ±  0.5  21 4 +  1.9  ND§§§  7.1  ±  2.411 ¶  0.31  ±  0.09¶I I 
* Reaction  mixtures  (in duplicate)  contained  0.1  ml of NBT  (2  mg/ml); 0.25  ml of the  suspension  of Candida,  2 /Lm  latex  particles, or 
Toxoplasma  (or,  in controls,  0.25  ml  KRPG);  0.5  ml of cell  preparations  that  contained  1.5  x  10  n monocytes  or  macrophages;  and 
sufficient  KRPG to effect  a  final volume of 1 ml in siliconized glass tubes. The final ratio of organisms or particles to cells was  10:1  for 
Candida, 2600:1  for 2 #m latex particles, and 25:1-30: I  for Toxoplasma. 
:~ Nanomoles of NBT reduced  (red.)  per 10  n monocytes or macrophages per 30 rain. 
§ Increase in nanomoles of NBT reduced per 106 monocytes or macrophage~ per 30 rain after subtraction of values for resting leukocytes and 
for organisms alone. Candida and latex particles alone did not reduce  NBT. NBT reduction by Toxoplasma preparations alone was 24 
±  0.5, 0.3 ±  0.3, and  1r2 ±  0.5 nmol/30 min for experiments with human MCP, human macrophage cell preparations,  and mouse MCP, 
respectively. 
t] Increase in NBT reduction during phagocytosis of Toxoplasma/increase  in NBT reduction during phagocytosis of Candida. 
I  Numbers in parentheses  are the number of experiments performed with controls, Candida, and Toxop]asma;  the number of experiments 
with latex particles was 4, 2, and 2 for human MCP, human macrophage cell preparations, and norr,.~l nlouse MCP, respectively. 
** MCP from normal mice. 
:~:~ MCP from mice given 1,400 ~g formalin-killed C. par~um intraperitoneally  7 d  previously. 
§§ MCP from mice chronically infected with C56 strain of Toxoplasma. 
fill Mean ±  SEM. 
I¶ P<  0.005 compared with human MCP. 
***  P <  0.001 compared with human MCP and human macrophage cell preparations. 
*$* P <  0.001 compared with human MCP. 
§§§ ND, not determined. 
I]][ll P <  0.02 compared with mouse MCP from age-matched  normal controls that  were studied in parallel. 
111 P<  0.05 compared with mouse MCP from age-matched  normal controls that  were studied in parallel. 
(Candida 38.6 +_ 6.7 nmol; Toxoplasma  11.7  +  1.4 nmol), in three experiments with 
normal mouse MCP  (Candida  15.5  +  4.2 nmol; Toxoplasma 0.7 _  0.5 nmol), and in 
two experiments with human macrophages (Exp.  1: Candida 43.8 nmol, Toxoplasma 
6.4 nmol; Exp.  2:  Candida  18.1  nmol, Toxoplasma  1.2 nmol). 
MCP from mice chronically infected with Toxoplasma or from mice injected with 
C. parvum (MCP  that  contained activated  macrophages)  reduced  significantly  more 
NBT  during  phagocytosis  of Toxoplasma  than  did  normal mouse MCP  (Table  I). 
Mouse MCP  that contained activated  macrophages also reduced more NBT  during 
phagocytosis  of Candida  than  did  normal  mouse MCP;  however,  these  differences 
were not significant. 
To determine whether phagocytosis of Toxoplasma failed to stimulate or inhibited 
NBT reduction by normal mouse or human MCP,  two experiments were performed 
in which these cell  preparations were challenged with Toxoplasma  (or, as a control, 
an  equal  volume of KRPG)  and  after  15  min  also challenged  with  Candida.  The 
reaction was then allowed to proceed for 30 rain. NBT reduction during phagocytosis 
of Toxoplasma and Candida (12.6 +  1.9 nmol) by normal mouse MCP did not differ 
significantly  from NBT reduction during phagocytosis of Candida  alone (10.7  +  0.2 
nmol). Results in the experiments with human MCP  were comparable. Thus, phag- 
ocytosis of Toxoplasma did not inhibit NBT reduction. 
Because Toxoplasma were obtained from the peritoneal cavities of mice, something 
in the Toxoplasma  preparations other than organisms might  have been responsible c.  B.  WILSON, V. TSAI, AND J.  s.  REMINGTON 
TABLE  II 
Contribution of Different Types of Leukocytes to Reduction of NBT 
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Cell preparation 
Mononuclear*  PMN:~  Monocyte depleted§  Monocyte enrichedll 
Source of cells  Toxo-  Toxo-  Toxo-  Toxo- 
Candida¶  plasma¶  Candida  plasma  Candida  plasma  Candida  plasma 
tt NBT red **  tt NBT red.  ~. NBT red.  A NBT red.  A NBT red.  A NBT  A NBT red.  A NBT red. 
red. 
Human  (2):~:~  74.7 +  29§§  21.5 +  4.7  10.0 ±  3.9  1.8  43.9 ±  00  13.9 ±  1.8 
Human  (3)  39.3 ±  17,9  8,6 ±  3.9  3.2 ±  3.2  0.D ±  0.0 
Mouse (2)  34.6 ±  13.6  NDIIll  4.6 ±  I.I  ND  ND  NI) 
Mouse (1)  32,1  ND  2.9  ND 
* Unseparated  MCP adjusted to contain  1.5 ×  106 monocytes (human) or normal macrophages (mouse). 
:~ Human  PMN cell preparations contained  >95%  PMN, and PMN reaction  mixture~ contained  1.5 ×  105 PMN;  in the same experiments, 
MCP contained 0-1.4 x  l0  s PMN. The mouse PMN-enriched cell preparation contained 53% PMN, and PMN reaction mixture contained 
7.5 ×  104 PMN;  the corresponding MCP contained 3  x  104 PMN. 
§ MCP depleted of monocytes (human) or macrophages (mouse). Reaction mixtures contained lymphocytes in a  number equal to that in the 
initial MCP and contained =25% the number of human monocytes or ~  15% the number of normal mouse macrophages in the initial MCP. 
Viability was 98-99% by trypan blue exclusion. 
II Freshly isolated mononuclear cells were allowed to adhere to glass for 30 min, washed  to remove nonadherent  cells, and  re,suspended  as 
described for human macrophages (see  text). The reaction mixtures contained an equal number of monocytes but  1@~ as many lymphocytes 
as the initial MCP. Viability was 100% by trypan blue exclusion. 
¶  Phagocytic stimulus. 
** Increase  in nanomoles of NBT reduced  (red.)  per reaction  mixture per 30 min after subtraction  of values for resting leukocytes and  for 
organisms alone. 
:~:~ Numbers in parentheses are the number of experiments performed. 
§§ Mean •  SEM. Single experiment where no SEM is shown. 
III1  ND, not determined. 
for stimulation of NBT reduction  by human  MCP.  However, addition of supernate 
from  a  Toxoplasma  preparation  did  not  stimulate  NBT  reduction  by  these  cell 
preparations. 
The procedure used to prepare suspensions of human macrophages did not result 
in their inability to reduce NBT during phagocytosis of Toxoplasma. NBT reduction 
during phagocytosis of Toxoplasma by human adherent  mononuclear cells (75-80% 
monocytes) that were resuspended 45 min after addition  to glass Petri dishes by the 
same procedure used to resuspend human macrophages was similar to that observed 
with the initial MCP  (Table II). Also, the ratios of NBT reduction  (90-min reaction 
period) during phagocytosis of Toxop[asma to those during phagocytosis of Candida 
by monolayers of human monocytes (Toxoplasma  13.6  nmol/Candida  35.0 nmol = 
0.39)  and  by monolayers of human  macrophages  (Toxoplasma 2.7  nmol/Candida 
40.7  nmol  =  0.07)  were  similar  to  ratios  obtained  with  the  corrresponding  cell 
preparations in suspension. 
As reported by others  (22,  29-31),  SOD or SOD adsorbed to latex particles  (but 
not inactivated SOD) partially inhibited NBT reduction in a concentration-dependent 
fashion  (data not shown). These data indicate the role of superoxide anion  (02-)  in 
NBT reduction by intact phagocytes. 
Phagocytosis  of Organisms.  Phagocytosis of  Candida and Toxoplasma by the different 
types of mononuclear phagocytes is shown in Table III. Because results of phagocytosis 
in experiments on quantitative  NBT reduction  and  14CO2 production  were similar, 
they  have  been  pooled.  The  data  show  that  human  monocytes  ingested  fewer 
Toxoplasma than did human or mouse macrophages. To allow comparison with the 
amount of NBT reduced,  we calculated  the ratio of the mean phagocytic index  for 334  SURVIVAL OF INTRACELLULAR PATHOGENS WITHIN MACROPHAGES 
TABLE III 
Phagocytosis of Organisms* 
Cell preparation 
Organism 
Candida  Toxoplasma 
Human mononuclear (11)~  2.8 -  0.3**  0.7 -  0.1 
Human macrophage (4)  4.5 ± 0.6  2.4 + 0.9 
Mouse mononuclear 
Normal§ (16)  3.8 + 0.3  1.3 ± 0.1 
C. parvum[[ (4)  4.2 +  1.2  1.5 ± 0.2 
Chronic Toxoplasma¶  (5)  4.4 + 0.5  1.2 ± 0.4 
* Results in experiments on quantitative NBT reduction and 14CO2 produc- 
tion have been pooled because the values were similar. 
Numbers in parentheses are the number of determinations. 
§ MCP from normal mice. 
1[ MCP from mice given 1,400/~g formalin-killed C. parvum intraperitoneally 
7 d previously. 
¶ MCP from mice chronically infected with C56 strain of Toxoplasma. 
** Mean _+ SEM of phagocytic indices. 
Toxoplasma to the mean phagocytic index for Candida; the ratio was 0.25 for human 
monocytes, 0.53  for human  macrophages, and 0.34  for normal mouse macrophages. 
The ratio of NBT reduction by human  MCP  during phagocytosis of Toxoplasma to 
that  during  phagocytosis of Candida  (0.25  ±  0.04)  correlated with  the ratio of the 
phagocytic  indices  for  these  two  organisms.  The  ratios  of NBT  reduction  during 
phagocytosis  of Toxoplasma  to  that  during  phagocytosis  of  Candida  by  human 
macrophages  (P  <  0.005)  and  normal  mouse  MCP  (P  <  0.001)  (Table  I)  were 
significantly  less  than  that  by  human  MCP  and  were  far  below  what  would  be 
predicted on the basis of the phagocytic indices for these two organisms. In contrast, 
the  ratios  of  NBT  reduction  during  phagocytosis  of Toxoplasma  to  that  during 
phagocytosis  of  Candida  by  mouse  MCP  that  contained  activated  macrophages 
(Table I)  were similar to those observed with  human  MCP.  As noted, these experi- 
ments  were  performed  with  ratios  of organisms  to  phagocytes  that  were  found  in 
preliminary experiments to produce maximum  increments in metabolic activity and 
maximum phagocytic indices at the end of the reaction period. In three experiments 
with  normal  mouse  macrophages  and  one  with  human  macrophages,  lowering  the 
ratio of Toxoplasma to phagocytes so that  the phagocytic indices approached  those 
observed with human  monocytes was found to accentuate  the discrepancies in NBT 
reduction  during  phagocytosis of Toxoplasma  by  these  three  cell  types  (data  not 
shown). 
Contribution of Different  Types  of Leukocytes to  Reduction of NBT.  Although  human 
macrophage cell preparations contained only macrophages, human  and mouse MCP 
contained  both  mononuclear  phagocytes  and  lymphocytes,  and  some  preparations 
contained  a  small  number  of PMN.  To  determine  whether  PMN  or  lymphocytes 
significantly contributed to NBT reduction by MCP, human  PMN- or mouse PMN- 
enriched cell preparations and human and normal mouse MCP  that were intention- 
ally depleted of monocytes or macrophages were studied in parallel with the appro- 
priate MCP. PMN could account for <10% ofphagocytosis-stimulated NBT reduction 
by human  and  mouse  MCP  (Table II). Phagocytosis-stimulated NBT  reduction  by C.  B.  WILSON, V.  TSAI, AND J.  S.  REMINGTON 
TAaLE IV 




Cells that contain organisms× 100 
total cells 
Cells that contain formazan- 
stained organisms X 100 
Cells that contain organisms 
Candida  Toxoplasma  Toxoplasma  Candida  Toxoplasma  Toxoplasma 
0.5 h:~  lh  2h  0.5h  1 h  2h 
Human mon-  84+4§(6)11  27+-6  (6)  12+6  (3)  82+5(6)  71+ 7 (6)  87+9  (3) 
ocyte 
Human  mac-  97+ 1 (2)  37+6  (3)  10(1)  85+5(2)  4+ 1 (3)¶  10(1) 
rophage 
Mouse  mac-  70+9  (5)  48+ 12 (5)  28+-20(2)  88+3 (5)**  2+ 1 (5)¶  7-4  (2) 
rophage 
* Monolayers were prepared by adding MCP that  contained  1 ×  10  6  monocytes (human) or normal 
macrophages (mouse) to glass slide tissue culture chambers. Nonadherent cells were washed off after 1 
h. Human monocyte and normal mouse macrophage monolayers were challenged immediately with 
organisms. Human macrophage monolayers were challenged after 5-6 d of in vitro culture (see text). 
:~ Time after addition of organisms to monolayers. 
§ Mean -+ SEM. Single experiment where no SEM is shown. 
1] Numbers in parentheses are the number of experiments performed. 
¶ P < 0.001 compared with human monocytes. 
** P < 0.05 compared with human monocytes. 
human MCP was ~7-10 times greater than that by monocyte-depleted preparations 
that contained equal numbers of lymphocytes but only =  25% as many monocytes. 
Similar results  were  obtained with  mouse  macrophage-depleted  cell  preparations. 
Additional experiments were performed with cell preparations that had been depleted 
of lymphocytes: Results with monolayers of mouse macrophages and with monolayers 
of human monocytes (>90%  macrophages or  monocytes; <10%  lymphocytes) were 
similar to those with cell suspensions (data not shown); results with human monocyte- 
enriched cell preparations in suspension (75-80% monocytes; Table II) were similar 
to  those  with  the  initial MCP.  Also,  in the  experiments in Table I,  in which  the 
number of monocytes or macrophages in reaction mixtures was constant (1.5 X  106) 
and the number of lymphocytes varied, there was no significant correlation between 
the number of lymphocytes and the amount of NBT reduced by human (r =  -0.26; 
P  >  0.2)  or  mouse  (r  =  -0.4;  P  >  0.1)  MCP.  We conclude, therefore,  that  NBT 
reduction by human and mouse MCP was a  result of monocytes and macrophages, 
respectively. 
Intracellular Location  of Reduced NBT.  30 min after challenge with Candida, one or 
more formazan-stained organisms was  present in =  80% of each  cell type that  had 
ingested the organism (Table IV).  1 h  after challenge with Toxoplasma, one or more 
formazan-stained organisms was present in 71 +  7% of monocytes but only in 4 +  1% 
of human macrophages and 2 +  1% of normal mouse macrophages that had ingested 
Toxoplasma. The  difference between human monocytes and both  types of macro- 
phages is significant (P <  0.001). Similar results were obtained with monolayers that 
were  incubated for  2  h  (Table IV)  and 3  h  (data  not shown)  after challenge with 
Toxoplasma. These differences are illustrated in Fig.  1. As noted in the quantitative 
assays, Toxoplasma did not inhibit NBT reduction because macrophages that ingested 336  SURVIVAL OF  INTRACELLULAR  PATHOGENS  WITHIN  MACROPHAGES 
Fro.  1.  Reduction of NBT within phagocytic vacuoles. (A)  Human monocyte, (B) normal mouse 
macrophage, and  (C)  human  macrophage that have ingested Candida  (x  1,500);  the majority of 
Candida are stained by formazan precipitate, which appears darker black (arrow), within phagocytic 
vacuoles in each of these cell types. (D) Human monocytes that have ingested Toxoplasma (×  1,800) ; 
the majority of Toxoplasma are completely or partially stained by formazan  precipitate (arrow) 
within phagocytic vacuoles. (E)  Normal mouse macrophage and (F) human macrophage that have 
ingested Toxoplasma (×  1,800);  the Toxoplasma within phagocytic vacuoles of these cell types are 
not stained by formazan precipitate. C.  B.  WILSON, V.  TSAI,  AND J.  S.  REMINGTON 
TABLE  V 
Quantitative Reduction of NBT during Phagocytosis of Antibody-coated Toxoplasma * 
337 
Phagocytic stimulus 
None  Candida  Toxoplasma in non-  Toxoplasma in immune 
Cell preparation  immune seruml]  serumll 
A NBT 
NBT red.~  red.§  A NBT red.  A NBT red. 
Human macrophage (2)¶  3.3 ±  3.3**  54.3 ±  0.7  2.9 ±  0.2 [2.0]:~:~  21.4 ±  2.9 [3.1]§§ 
Mouse mononuclear (4)  2.6 + 0.2  17.4 +  2.4  1.4 +  0.0 [1.6 ±  0.1]  12.6 +  1.2 [2.4 ±  o.1]HII 
* Reaction mixtures  (in duplicate)  contained 0.1  ml of NBT (2 mg/ml); 0.25  ml of the suspension  of 
Candida or Toxoplasma (or, in controls, 0.25 ml KRPG); 0.5 ml of cell preparations that contained  1.5 
X 10  6 human macrophages or normal mouse macrophages; and sufficient KRPG to effect a final volume 
of 1 ml in siliconized glass tubes. 
Nanomoles of NBT reduced per  10  6 macrophages per 30 min. 
§ Increase  in nanomoles of NBT reduced per l0  s macrophages per 30 min after subtraction of values for 
resting leukocytes and for organisms alone. Candida did not reduce NBT. NBT reduction by Toxoplasma 
preparations alone was 0.7 -+ 0.3 nmol/30 min for all experiments. 
II See text. 
¶ Numbers in parentheses  are the number of experiments performed. 
** Mean +  SEM. 
:~ Numbers in brackets  are the mean +  SEM of phagocytic indices; where no SEM is shown, results were 
determined in a single experiment. 
§§ P <  0.05 compared with human macrophages phagocytosing Toxoplasma preincubated in nonimmune 
serum. 
HII P <  0.001 compared with normal mouse MCP phagocytosing Toxoplasma preincubated in nonimmune 
serum. 
both Candida  and Toxoplasma  contained formazan-stained  Candida  as frequently as 
did macrophages  that  ingested only Candida. 
Quantitative  Reduction  of  NBT  During  Phagocytosis  of  Antibody-coated  Toxoplasma. 
Incubation  of Toxoplasma  in  heat-inactivated  serum  that  contained  Toxoplasma 
antibody allows normal  human  and  mouse macrophages  to kill this organism  (7,  13). 
We considered  that  specific antibody  might  act  as a  trigger  for the respiratory  burst 
of human  and  mouse macrophages  during phagocytosis  of Toxoplasma.  NBT  reduc- 
tion  by  human  macrophages  and  by  normal  mouse  MCP  during  phagocytosis  of 
Toxoplasma  preincubated  in either homologous  or heterologous  immune  serum  was 
significantly  greater  than  that  which  occurred  during  phagocytosis  of Toxoplasma 
preincubated  in  nonimmune  serum  and  was  much  greater  than  the  increase  in 
number  of organisms ingested  (Table V), In two experiments with human  monocytes 
(data not shown),  there was a  twofold increase in NBT  reduction during phagocytosis 
of Toxoplasma  preincubated  in  immune  serum  compared  with  that  during  phago- 
cytosis  of Toxoplasma  preincubated  in  nonimmune  serum  and  a  similar  twofold 
increase in number  of organisms  ingested. 
Chemiluminescence.  Chemiluminescence,  like NBT  reduction,  is associated with the 
phagocytosis-associated  bur:~t of oxidative metabolic activity by leukocytes (25).  Each 
type  of  cell  preparation  that  was  studied  showed  significant  chemiluminescence 
during  phagocytosis  of Candida  (Fig.  2).  In  contrast,  only  human  MCP  showed  a 
definite  increase  in  chemii,lminescence  during  phagocytosis  of Toxoplasma.  As  ob- 
served in  the other assays,  the differences in chemiluminescence  during  phagocytosis 
of Toxoplasma  contrasted  with  the observations  on  phagocytosis;  human  monocytes 
ingested fewer Toxoplasma  than  did human  or normal  mouse macrophages,  and  the 338  SURVIVAL  OF  INTRACELLULAR  PATHOGENS  WITHIN  MACROPHAGES 
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FIG.  2.  Chemiluminescence during phagocytosis of Candida and Toxoplasma. Reaction mixtures 
in  15-ml siliconized glass scintillation vials (which had been stored in the dark >  24 h  before use) 
consisted of cell preparations that contained 4  x  106 monoeytes or macrophages; 10% human type 
AB serum (DT negative); 4  X  10 7 Candida or 1 x  l0  s Toxoplasma; and KRPG  to effect a  final 
volume of 2 ml. Controls contained no organisms. Results are expressed as mean +  SEM of counts 
per  minute from a  representative experiment of four with human MCP  (A),  two  with human 
macrophage cell preparations (B), and four with normal mouse MCP (C). 
ratio of Toxoplasma:Candida  ingested  by  human  monocytes was less  than  that  by 
human or normal mouse macrophages. Chemiluminescence was dependent upon O2-, 
as  shown  in  two  experiments  in  which  SOD  (250  #g/ml)  inhibited  83  -  6%  of 
maximum  phagocytosis-associated  chemiluminescence  both  by  human  and  mouse 
MCP.  Human  and  mouse  PMN  in  the  numbers  present  in  vials  that  contained 
human or mouse MCP did not emit detectable chemiluminescence during phagocy- 
tosis of Candida or Toxoplasma. Because lymphocytes do not emit or inhibit chemi- 
luminescence  (32,  33),  we conclude  that  chemiluminescence  by  human  and  mouse 
MCP was a result of monocytes and macrophages, respectively. 
14C02 Production  from [1-14C]glucose.  ~4CO2  production from [1-a4C]glucose by each 
type of cell preparation  that was studied  increased significantly  during phagocytosis 
of Candida  (Table  VI).  The  increase  in  14CO2 production  by  human  MCP  was 
significantly greater (P <  0.02)  than that by normal mouse MCP during phagocytosis 
of Toxoplasma;  there was no increase in  X4CO2 production by human macrophages 
during  phagocytosis  of Toxoplasma.  This  contrasted  with  results  of phagocytosis 
(Table ]II). 
Lymphocytes and  PMN  present  in  human and  mouse MCP  did  not account  for 
the  phagocytosis-associated  increase  in  glucose  oxidation.  Maximum  counts  per 
minute for phagocytosing human or mouse PMN in numbers equal to or greater than 
the  numbers  present  in  corresponding  MCP  were  309  and  85  +  42,  respectively, 
which is <  3% ofcpm for phagocytosing human and mouse MCP. Similar experiments 
with  monocyte-  (human)  or  macrophage-  (mouse)  depleted  MCP  indicated  that 
lymphocytes could  account  for <  3%  of the  increase in  ]4COz produced  by  human 
and mouse MCP during phagocytosis. 
Although Toxoplasma alone produced substantial  amounts of 14CO2, the increase 
in  glucose oxidation  during phagocytosis  of this organism  did  not  reflect  increased 
glucose oxidation by the organism itself. Phagocytosis of formalin-killed (1% formalin 
in  PBS  for  1 h)  organisms, compared with viable  organisms, was associated  with  a C.  B. WILSON, V. TSAI, AND J.  S.  REMINGTON  339 
TABLE VI 
14C02 Production  from [ l )4C]glucose* 
Phagocytic stimulus 
Cell preparation  None  Candida  Toxoplasma  A cpm Toxo- 
plasma/A cpm 
cpm:~  cpm  A cpm§  corn  A cpm  Candidal{ 
Human  mononuclear (5)¶  404 ±  88**  4,479 4- 642  4,096 "¢- 508  2,739 +  549  1,720 +  377  0.41  -4- 0.06 
Human macrophage  (2)  568 4-  152  3,305 ±  887  2,737 ±  735  804 ±  50  0 ±  0:~*  0.00 +  0.00§§ 
Mouse mononuclear (6)  268 ±  34  2,259 +  272  1,991  ±  300~  1,307 4- 227  541  :t:  153][11  0.29 ±  0.10 
* Reaction  mixtures consisted  of cell  preparations  that  contained  4  ×  106 monocytes  or  normal  mouse  macrophages  or  ~/  ×  10  ~ human 
macrophages;  4  ×  107 Candida or  1 ×  l08 Toxoplasma; 0.25 txCi of [l-x4C]glucose (56.8 mCi/mmol sp act:  Amersham Corp.,  Arlington 
Heights, Ill.); and KRPG to effect a  final volume of l.I ml in duplicate center-well Erlenmeyer flasks. For determination of resting activity, 
organisms were omitted. 
:~ Counts per minute of t4CO2 released per 4 X  106 monocytes or normal mouse macrophages per 60 rain or 2 x  106 human macrophages per 
60 mln. 
§ Increase in counts per minute of t4CO2  released after subtraction of values for resting leukocytes and for organisms alone. Candida alone did 
not release J¢CO2.  t4CO~  release by Toxoplasma preparations  alone was 771  +  131,  775 4- 31, and 527 :t:  125 cpm for experiments  with 
human MCP, human macrophage cell preparations, and normal mouse MCP, respectively. 
]] Increase in counts per minute during phagocytosis of Toxoplasma/increase  in counts per minute during phagocytosls of Candida 
¶ Numbers in parentheses are the number of experiments performed, 
** Mean +  SEM. 
:~:~ P<  0.05 compared with human MCP, 
§§ P<  0.01 compared with human MCP. 
[111 P<  0.02 compared with human MCP. 
somewhat greater increase in glucose oxidation by human MCP  (A cpm live Toxo- 
plasma =  1,170;  A cpm dead Toxoplasma -- 2,553) and by mouse MCP (A cpm live 
Toxoplasma =  738; A cpm dead Toxoplasma =  876); data are representative of two 
experiments. In addition, aerobic glycolysis was shown to be the primary pathway by 
which Toxoplasma oxidized glucose because Toxoplasma organisms produced 14CO2 
from  [6)4C]glucose  (cpm  ffi 679)  and  [1)4C]glucose  (cpm  =  538)  in  comparable 
amounts;  in  contrast,  the  hexose  monophosphate  (HMP)  shunt  was  the  primary 
pathway  by  which  glucose  oxidation  increased  during  phagocytosis  because  the 
increase in phagocytosis-associated X4CO2 production from [6-14C]glucose  was <  10% 
of that from [1-14C]glucose. 
Intracellular  Survival  and Replication  of Toxoplasma.  Each  cell  type was  studied  to 
determine the fate of ingested Toxoplasma. As shown in Fig. 3, there was a  marked 
decrease in  the  percentage of human  monocytes infected  20  h  after challenge  in 
comparison to  the  percentage infected at  1 h  after challenge;  the  decrease  in  the 
percentage of infected human  macrophages  and  normal  mouse  macrophages  was 
significantly less (P <  0.01 and P <  0.001, respectively). Also, intracellular replication 
of the organism was less in human monocytes than in human macrophages (P <  0.01) 
or in normal mouse macrophages (P <  0.001). Examination of cytocentrifuge prepa- 
rations of culture supernates from each type of monolayer never revealed more than 
two infected nonadherent cells; thus, loss of infected cells from monolayers did not 
account  for the differences observed. We have obtained similar results  in  previous 
experiments using a radiolabel technique that measures selective uptake of [3H]uracil 
by Toxoplasma replicating intracellularly and which is not dependent upon adherence 
of cells to the monolayer or on microscopic observations (11). 
The data noted above showed a correlation between intracellular killing of Toxo- 
plasma by mononuclear phagocytes and activation of the oxidative metabolic burst 
during phagocytosis of this organism. We therefore studied the killing of Toxoplasma 
by monocytes from a child with X-linked CGD, his mother, and his sister in parallel 340  SURVIVAL OF INTRACELLULAR PATHOGENS  WITttIN MACROPttAGES 
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FIG. 3.  Fate of Toxoplasma within  mononuclear  phagocytes. Results are mean +  SEM from 11 
experiments with human monocytes, 5 experiments with human macrophages, and 11 experiments 
with normal  mouse macrophages. In all experiments with human macrophages, monocytes from 
the same subject were studied in parallel.  (O) Human monocytes, ([-1) human macrophages, and 
(0)  normal  mouse macrophages. The abscissa shows the time after addition of Toxoplasma  to 
monolayers. (A) Percentage of cells that contained  Toxoplasma.  (B)  Replication  of Toxoplasma 
expressed as mean number of organisms per vacuole. *P <  0.01 compared with human monocytes; 
J'P <  0.001 compared with human monocytes, P <  0.01 compared with human macrophages; :~P 
< 0.001 compared with human  monocytes. 
with monocytes from a normal adult control; values for NBT reduction and hydrogen 
peroxide (H202)  release by leukocytes from these subjects are shown in Fig. 4. Killing 
of Toxoplasma by monocytes from  the affected child and  his mother was markedly 
less 6 h  after challenge and somewhat less 20 h after challenge than that by monocytes 
from  his sister and  the control  (Fig.  4).  However,  Toxoplasma  did not  replicate in 
monocytes from any of these subjects. Our attempts in these and other experiments to 
block  the  anti-Toxoplasma  activity  of  monocytes  by  inhibitors  of  some  oxygen- 
independent mechanisms have been unsuccessful. Addition of heparin (100 U/ml; an 
inhibitor of lysosomal cationic  proteins)  or a-1  anti-trypsin  (2  mg/ml,  sufficient  to 
inhibit  2,000  N-Benzoyl-Arginine Ethyl  Ester units of trypsin;  an  inhibitor of tyso- 
somal neutral proteases)  to monolayers of monocytes from  the child with CGD  and 
his  mother  and  from  normal  subjects  or  addition  of  sodium  azide  (10 -3  M;  an 
inhibitor of myeloperoxidase) to monolayers of monocytes from  normal subjects did 
not affect survival and replication of Toxoplasma. 
Phagosome-Lysosome Fusion.  Fusion  of lysosomes with  phagosomes  that  contained 
Toxoplasma  paralleled destruction  of organisms.  In  three  experiments,  fusion  had 
occurred by 4 h after the addition of Toxoplasma to monolayers in 66 +  6% of human 
monocytes, 43  +  8% of macrophages from mice injected with C. parvum, 61  +  16%  of 
macrophages  from  mice  chronically  infected  with  Toxoplasma,  and  20  +  6%  of 
macrophages from normal mice. Subsequently (by 20 h  after challenge), Toxoplasma 
were eliminated from 97 _  1% of human  monocytes, 50 +  10% of macrophages from 
mice injected with C. parvum, 68 +  2% of macrophages from mice chronically infected 
with  Toxoplasma,  and  18  +  7%  of macrophages  from  normal  mice.  Although  the 
parasite replicated within nonfused phagosomes of normal mouse macrophages, it did 
not appear to replicate within nonfused phagosomes of human monocytes or activated 
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FIG.  4.  Fate of Toxoplasma within monocytes from a  child with X-linked CGD  (A), his hetero- 
zygote mother (O), his normal sister ([X), and an unrelated normal control (O). The abscissa shows 
the  time  after  addition  of Toxoplasma  to  monolayers.  (A)  Percentage  of cells  that  contained 
Toxoplasma. (B)  Replication of Toxoplasma, expressed as mean number of organisms per vacuole. 
Results  of  phagocytosis-associated  (Candida)  and  phorbol  myristate  acetate  stimulated  NBT 
reduction and H202 release by leukocytes. HzOz release was determined by the method of Root et 
al. (27).  Means: child, 8% of control; mother, 31% of control; sister,  124% of control• 
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Discussion 
Our  results  reveal  that  mononuclear  phagocytes  that  generate  reactive  oxygen 
metabolites during phagocytosis of Toxoplasma are able to kill this organism and to 
inhibit intracellular replication of those few organisms that are not killed. In contrast, 
mononuclear phagocytes that generate little or no reactive oxygen metabolites during 
phagocytosis of Toxoplasma are unable  to kill this organism and  do not  inhibit  its 
intracellular replication. 
In  each  of  the  assays  we  employed,  phagocytosis  of  Toxoplasma  significantly 
stimulated oxidative metabolic activity by human monocytes, whereas in none of the 
assays  did  phagocytosis of Toxoplasma significantly  stimulate  oxidative  metabolic 
activity  by  human  macrophages.  Results  with  normal  mouse  macrophages  were 
similar to those with human macrophages, except that phagocytosis of Toxoplasma 
by mouse macrophages did stimulate  increased  HMP shunt  activity;  however, this 
increase was significantly less than  that  observed with  human  monocytes.  Previous 
studies have also found that HMP shunt  activity does not necessarily correlate with 
production of 02- and H202  (34, 35). 
Differences  between  mononuclear  phagocytes  in  generation  of reactive  oxygen 
metabolites during phagocytosis of Toxoplasma could not be explained by differences 
in  phagocytosis.  Human  monocytes actually  ingested  fewer Toxoplasma,  either  in 
absolute terms or relative to the numbers of Candida  ingested, than  did human or 
mouse macrophages. Microscopic observations confirmed the differences noted in the 
quantitative assays of oxidative metabolic activity; O~- (as indicated by the presence 
of  formazan  precipitate)  was  present  within  phagScytic  vacuoles  that  contained 
Toxoplasma in  nearly  all  human  monocytes but  only  in  rare  normal  human  and 
mouse macrophages. 
Previous studies of the role of oxidative metabolism in the microbicidal activity of 
macrophages have shown that activated macrophages, which have increased antimi- 342  SURVIVAL  OF  INTRACELLULAR PATHOGENS WITHIN MACROPHAGES 
crobial  activity,  generate  increased  amounts  of reactive  oxygen  metabolites  when 
triggered by particulate and chemical agents such as zymosan and phorbol myristate 
acetate  (3-5,  36).  This  suggests  that  differences  in  maximum  oxidative  metabolic 
response between mononuclear phagocytes of different types or of different degrees of 
activation to such general triggering agents may be causally related to differences in 
antimicrobial activity. We observed only a partial correlation between generation of 
reactive  oxygen  metabolites  by  different  types  of mononuclear  phagocytes  when 
triggered by phagocytosis of Candida or latex particles and the ability of these cells 
to kill Toxoplasma. However, consistent correlation was observed between killing of 
Toxoplasma and generation of reactive oxygen metabolites when triggered by phag- 
ocytosis  of Toxoplasma.  Thus,  whereas  human  macrophages  and  normal  mouse 
macrophages  generated  little  or  no  H202  and  reduced  little  or  no  NBT  when 
phagocytosing nonopsonized  Toxoplasma, human  monocytes and  activated  mouse 
macrophages  did.  Furthermore,  human  macrophages  and  normal  mouse  macro- 
phages, which  kill opsonized Toxoplasma,  did  reduce  significant  amounts  of NBT 
when  phagocytosing opsonized Toxoplasma. These data suggest  that  differences in 
the  ability  of mononuclear  phagocytes  to  generate  increased  amounts  of reactive 
oxygen  metabolites  during  phagocytosis  of specific  organisms,  rather  than  or  in 
addition  to differences in their oxidative metabolic activity in response to unrelated 
particulate or chemical-triggering agents,  may account  for differences in  their anti- 
microbial activity. 
The results of our studies with monocytes from a  patient with X-linked CGD and 
his  heterozygote  mother  indicate  that  oxygen-dependent  mechanisms  contribute 
significantly to early and efficient killing of Toxoplasma by these cells but that other 
less  efficient  nonoxidative reserve mechanisms are capable of killing this organism. 
Murray  et  al.  (37),  studying  activated  mouse  macrophages,  also  concluded  that 
reactive oxygen metabolites play a role in the ability of these cells to kill Toxoplasma. 
We observed both increased oxidative metabolic activity and increased phagosome- 
lysosome fusion  during  phagocytosis  of Toxoplasma by  those  cells  that  killed  the 
organism  (human  monocytes and  activated  mouse  macrophages).  Thus,  lysosomal 
contents  may  normally  act  in  concert  with  reactive  oxygen  metabolites  to  kill 
Toxoplasma.  In  addition,  lysosomal  contents  may  be  a  less  efficient  mechanism 
whereby Toxoplasma is killed by cells that fail to generate reactive oxygen metabolites 
during  phagocytosis  of  this  organism.  Although  it  is  likely  that  reactive  oxygen 
metabolites and perhaps lysosomal contents as well are first-line mechanisms whereby 
mononuclear phagocytes kill Toxoplasma, both reactive oxygen metabolites and other 
mechanisms (as yet undefined and apparently nonlysosomal) may participate in the 
ability  of  these  cells  to  inhibit  replication  of surviving  organisms.  Even  though 
lysosomes did not fuse with phagosomes that contained  those rare Toxoplasma that 
were not  killed by human  monocytes, these organisms replicated more slowly than 
did Toxoplasma within normal human or mouse macrophages. As Jones (38)  and we 
observed,  this  was  also  true  for those  organisms  that  were  not  killed  by activated 
mouse macrophages. Therefore, nonlysosomal mechanisms must account  for inhibi- 
tion  of replication  of Toxoplasma within  mononuclear phagocytes. Additional  evi- 
dence  that  supports  this  conclusion  is  our observation  that  inhibitors  of lysosomal 
cationic  proteins,  neutral  proteases, or myeloperoxidase did  not  alter the  ability of 
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kill  or inhibit  replication of Toxoplasma. Others  have found that  reactive oxygen 
metabolites contribute to inhibition of  Toxoplasma replication within activated mouse 
macrophages (37). Although we observed that Toxoplasma failed to replicate within 
monocytes from a patient with X-linked CGD and his mother, this does not exclude 
participation of reactive oxygen metabolites in  the inhibition of Toxoplasma repli- 
cation  by monocytes from normal  subjects.  Thus,  the ability of some intracellular 
pathogens to be phagocytosed without triggering the oxidative metabolic burst may 
be necessary, although not always sufficient, for their survival. That such a mechanism 
for the survival of intracellular pathogens is not unique to Toxoplasma is suggested 
by the ability of virulent Salmonella typhi  (39)  and Brucella abortus (40)  to be phagocy- 
tosed  by PMN  without  stimulating  increased  HMP  shunt  activity and  to  survive 
within these cells. 
A  number of possible  mechanisms  were examined in  an  attempt  to explain  the 
differences that  we observed in  the oxidative metabolism of the  different types of 
mononuclear phagocytes during phagocytosis of Toxoplasma. Toxoplasma did  not 
inhibit  the oxidative metabolic response because monocytes and  macrophages that 
phagocytosed both Candida and Toxoplasma were able to reduce NBT as well as did 
those  that  phagocytosed  Candida  alone.  The  differences  in  oxidative  metabolic 
response were also not dependent upon Toxoplasma viability; results of HMP shunt 
activity  (as  noted  above)  and  NBT  reduction  (C.  B.  Wilson,  V.  Tsai,  and  J.  S. 
Remington.  Unpublished  observations.)  during phagocytosis of viable Toxoplasma 
by monocytes and normal mouse macrophages were similar to results during phago- 
cytosis of formalin-killed organisms.  Interestingly, phagocytosis of boiled organisms 
was a poor stimulus for NBT reduction and H202 production by these cell types (C. 
B. Wilson, V. Tsai, and J. S. Remington. Unpublished observations.). We found that 
the  differences in  oxidative metabolic  response could be overcome by coating  the 
organisms with antibody;  attachment  of antibody-coated Toxoplasma, presumably 
by IgG-Fc receptors, triggered both phagocytosis and the respiratory burst  by each 
type  of  mononuclear  phagocyte.  Thus,  these  data  suggest  that  both  structural 
(presumably  membrane)  integrity  of  the  organism,  which  is  altered  by  specific 
antibody or by boiling but  not  by formalin, and  differences between mononuclear 
phagocytes in their mechanisms for activation of the respiratory burst dictate whether 
attachment of nonopsonized Toxoplasma will trigger the respiratory burst as well as 
phagocytosis. 
Both  maturation  and  activation  of mononuclear phagocytes are  associated  with 
marked alterations of plasma membrane proteins and with alterations in membrane 
receptors involved in  C3b-coated  particle ingestion  (41).  It  is  possible that  similar 
changes  in  mononuclear  phagocyte  membrane  receptors  are  responsible  for  the 
differences we  observed  in  activation  of the  respiratory burst  during  ingestion  of 
Toxoplasma. Certain alterations of phagocyte membranes have previously been shown 
to affect triggering of the respiratory burst  without  affecting phagocytosis (42, 43). 
Desialylation of leukocyte membranes blocks stimulation of O2- and H202 production 
but  not  HMP  shunt  activity  by  latex  phagocytosis  or  by  concanavalin  A  (42); 
inhibition of membrane sulfhydryl groups blocks stimulation of HMP shunt activity 
but  not  Oz-  or  H202  production  by the  same  agents  (43).  Similarly,  a  naturally 
occurring defect, thought  to be membrane related, in  activation of the respiratory 
burst  by  nonantibody-coated particles  has  been  observed  in  two  children  with  a 344  SURVIVAL  OF INTRACELLULAR PATHOGENS WITHIN MACROPHAGES 
variant of CGD (44);  phagocytosis of zymosan and latex particles did not trigger the 
respiratory burst  by their ieukocytes, whereas phagocytosis of IgG-coated latex did. 
The  differences  we  observed  between  mononuclear  phagocytes  were  selective  and 
were not a  result of the inability of normal macrophages to generate reactive oxygen 
metabolites during phagocytosis of non-IgG-coated particles other than Toxoplasma 
because normal macrophages reduced  NBT and  generated  H202  (C.  B. Wilson,  V. 
Tsai, and J.  S.  Remington.  Unpublished  observations.) during phagocytosis of latex 
particles. Although electron microscopy has revealed that attachment and ingestion 
of nonopsonized Toxoplasma is similar to that of antibody-coated particles  (13), the 
nature of phagocyte membrane receptors for Toxoplasma is unknown. Further studies 
to elucidate the nature of those receptors in different types of phagocytes are indicated. 
Such studies may reveal the basis for the differences between mononuclear phagocytes 
in  the  activation  of the  respiratory  burst  during  phagocytosis of Toxoplasma and 
increase our understanding of the mechanism by which phagocyte membranes control 
activation of the respiratory burst. 
Summary 
As previously reported, normal human monocytes (11)  and activated mouse mac- 
rophages (9) are able to kill or inhibit intracellular replication of Toxoplasma that are 
not antibody coated, whereas normal human and mouse macrophages are not  (7, 9). 
Each  of  these  types  of  mononuclear  phagocytes  is  able  to  kill  antibody-coated 
Toxoplasma. In our studies, phagocytosis of antibody-coated Toxoplasma stimulated 
the  respiratory  burst  by  each  of these  types  of mononuclear  phagocytes,  whereas 
phagocytosis of organisms that were not  antibody coated stimulated  the respiratory 
burst only by human monocytes and by activated mouse macrophages. Phagocytosis 
of Toxoplasma did not inhibit production of reactive oxygen metabolites by normal 
macrophages; rather, it  failed to stimulate their production.  Killing of Toxoplasma 
by monocytes  from  a  child  with  X-linked  chronic  granulomatous  disease  and  his 
heterozygote mother  was  impaired.  Thus,  reactive oxygen  metabolites,  perhaps  in 
conjunction  with  lysosomal contents,  appear  to  be  first-line  mechanisms  whereby 
mononuclear phagocytes kill this organism. We were not able to determine the exact 
mechanisms whereby mononuclear phagocytes inhibit the replication of those Toxo- 
plasma that were not killed, although both oxygen-dependent and other nonlysosomal 
mechanisms may be involved. The differences we observed in oxidative response to 
phagocytosis  of Toxoplasma  appear  to  be  one  determinant  of  the  antimicrobial 
activity of these cells and may account for the ability of some intracellular pathogens 
to survive within  phagocytes. These differences may be membrane related.  Further 
studies of Toxoplasma membranes, phagocyte membrane receptors for Toxoplasma, 
and membrane-related mechanisms for activation of the respiratory burst are needed 
to define their true basis. 
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